Jacobs Levy Equity Management
SGNT

Jacobs Levy Equity Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Jacobs Levy Equity Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-49,625
Closed -$743K – 1241
2016
Q2 		$743K Sell
49,625
-98,489
-66% -$1.27M 0.02% 660
2016
Q1 		$1.8M Buy
+148,114
New +$2.08M 0.04% 427
2015
Q1 		– Sell
-29,450
Closed -$739K – 950
2014
Q4 		$739K Buy
+29,450
New +$864K 0.01% 551
2014
Q2 		– Sell
-50,673
Closed -$1.18M – 1000
2014
Q1 		$1.18M Sell
50,673
-44,371
-47% -$970K 0.02% 500
2013
Q4 		$2.41M Buy
95,044
+21,883
+30% +$494K 0.04% 399
2013
Q3 		$1.49M Buy
+73,161
New +$1.63M 0.03% 459

Jacobs Levy Equity Management's SGNT Position: Q3 2016 in Review

Jacobs Levy Equity Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 49,625 shares — an estimated $743K sold.

Jacobs Levy Equity Management first reported a position in SGNT in Q3 2013 and held it in 6 quarters. The position peaked at $2.41M in Q4 2013. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Jacobs Levy Equity Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 49,625 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $743K.
  • Jacobs Levy Equity Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 6 quarters.
  • Jacobs Levy Equity Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.41M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.